Clinical Trial Update: Efficacy, Safety and Tolerability of Everolimus in Combination With Reduced Exposure Cyclosporine or Tacrolimus in Paediatric Liver Transplant Recipients. [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Everolimus with reduced exposure to cyclosporine or tacrolimus in pediatric liver transplant recipients, focusing on efficacy, safety…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Liver Disease

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Renal Function, Liver Transplant | Phase 3 | Status: COMPLETED | Results posted: 2017-01-24